Why the study?
Does pioglitazone improve coronary plaque composition and plasma adiponectin levels in patients with type 2 diabetes mellitus and stable angina pectoris?
Population
54 patients with type 2 diabetes mellitus and stable angina pectoris, scheduled for percutaneous coronary…
Comparison
Pioglitazone 15 mg/day added to existing… vs Continued previous antidiabetic regimen.
Design
RCT, Randomly assigned to the pioglitazone group or the control group., Open…
Follow-up
6 months
Authors
Loading...
Pioglitazone may stabilize plaques in T2DM patients with stable angina; extends evidence on adiponectin-mediated necrotic-core reduction.
Does pioglitazone improve coronary plaque composition and plasma adiponectin levels in patients with type 2 diabetes mellitus and stable angina pectoris?
Pioglitazone may stabilize coronary plaques in patients with type 2 diabetes by reducing the necrotic-core component, which correlates with increased plasma adiponectin levels.
Ogasawara et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: